
Senator · TX · R
Current term Jan 3, 2021 – Jan 3, 2027 · In the Senate since Nov 30, 2002
Official websiteContact formBiographical Directory
Portrait: U.S. Government Publishing Office, via unitedstates/images (public domain)
Lobbying reports (LD-2) whose issue descriptions explicitly cite a bill this member sponsored, cosponsored, or cast a recorded vote on. This documents an overlap in subject only. LD-2 reports generally do not name the members contacted, and a citation does not show contact with this member, influence, or the client's position on the bill. No matching record means none was found within coverage, not that no lobbying occurred.
Loading lobbying reportsCoverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 28, 2026. Only the current version of each report is used.
38,147 report citations, newest first.
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$3,150,000
Spent on own lobbying
CitesS. 2· this member:Recorded votes on 28 roll calls
….7837 Most Favored Patient Act of 2026 PL 119-75 Consolidated Appropriations Act of 2026 HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act HR 10628/ S 5571 Biosimilars Access and Affordability Act S 5244 Sustain 340B Act HR 9599 Secure 340B Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
$3,150,000
Spent on own lobbying
CitesS. 3345· this member:Cosponsored
…ess and treatment Issues related to reimbursement for biologics/biosimilars Issues related to PBM reform Issues related to bone disease awareness and treatment S.3345, PBM Price Transparency and Accountability Act HR 6166, Lowering Drug Costs for American Families Act S 3019 - No Big Blockbuster Bailouts Act S 3349 PBM Discl…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Taxation/Internal Revenue Code
$3,150,000
Spent on own lobbying
CitesH.Con.Res. 14· this member:Recorded votes on 23 roll calls
…tional tax Public Law 115-97, Tax Cuts and Jobs Act Public Law 119-21, One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) Issues related to Puerto Rico Issues related to OECD negotiations on the taxation of global income
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$3,150,000
Spent on own lobbying
CitesH.Con.Res. 14· this member:Recorded votes on 23 roll calls
…e Cures Act HR 1672 Maintaining Investments in New Innovation Act HR 1 One Big Beautiful Bill Act (An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act H.R.5526 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowerin…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$3,150,000
Spent on own lobbying
CitesS. 2· this member:Recorded votes on 28 roll calls
…Act HR 5256 340B Access Act HR 7391 Community Health Center Drug Pricing Protection Act HR 8143/S 4323 Ensuring Access to Lower-Cost Medicines for Seniors Act S.2, Secure America Act (Reconciliation 2.0) S 3014 Ensuring Timely Access to Generics Act of 2025 S 2355 Patients Deserve Price Tags Act HR 8646 Agriculture, Rura…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$3,150,000
Spent on own lobbying
CitesS. 3345· this member:Cosponsored
…to provide for reconciliation pursuant to title II of H. Con. Res. 14) S 1954 Biosimilar Red Tape Elimination Act H.R.5526 Biosimilar Red Tape Elimination Act S.3345 PBM Price Transparency and Accountability Act H.R. 6166 Lowering Drug Costs for American Families Act S.3019 No Big Blockbuster Bailouts Act HR 4317 PBM Reform…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$3,150,000
Spent on own lobbying
CitesS. 1040· this member:Sponsored
…nny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S 708/ HR 1574 -- Realizing Engineering, Science and Tech…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMGEN INC · lobbying firm or registrant: AMGEN, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Copyright/Patent/Trademark
$3,150,000
Spent on own lobbying
CitesS. 1041· this member:Sponsored
…RIPS Issues related to patent thickets Issues related to obviousness/ double patenting Issues related to FDA/PTO coordination Issues related to skinny labeling S.1041 A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S.1040 -A bill to a…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ROCKET LP FKA RKT HOLDINGS · lobbying firm or registrant: ROCKET LP FKA RKT HOLDINGS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Housing
$500,000
Spent on own lobbying
CitesH.R. 6644· this member:Recorded votes on 9 roll calls
…ding; National Flood Insurance Program; H.R. 6407, Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act of 2025 S.2651, ROAD to Housing Act of 2025 H.R. 6644- 21st Century ROAD to Housing Act; General Home Listing Platform Issues; H.R. R.9237, Take Care of Americas Veterans Act; S.4744, Take Care of Americas Veteran…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN LAND TITLE ASSOCIATION · lobbying firm or registrant: AMERICAN LAND TITLE ASSOCIATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Real Estate/Land Use/Conservation
$250,000
Spent on own lobbying
CitesH.R. 6644· this member:Recorded votes on 9 roll calls
…l HR 1640, Heirs Estate Inheritance Resolution and Succession Act of 2025, Whole bill HR 1608, Heirs Empowerment and Inheritance Rights Act of 2025, Whole bill HR 6644, 21st Century ROAD to Housing Act, whole bill H.R.5387 Save the American Dream Act, whole bill H.R. 4936, Taskforce for Recognizing and Averting Payment Scams…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SAVING COLLEGE SPORTS · lobbying firm or registrant: RESOLUTION PUBLIC AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Sports/Athletics
$90,000
Paid to lobbying firm
CitesS. 4668· this member:Recorded votes on 11 roll calls
S. 4668, the Protect College Sports Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
RALPH LAUREN CORPORATION · lobbying firm or registrant: AKIN GUMP STRAUSS HAUER & FELD
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Apparel/Clothing Industry/Textiles
$60,000
Paid to lobbying firm
CitesS. 1919· this member:Cosponsored
Issues related to trade/tariffs in apparel; Issues related to H.R. 7230/S.1919 - Buying American Cotton Act of 2026.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
RALPH LAUREN CORPORATION · lobbying firm or registrant: AKIN GUMP STRAUSS HAUER & FELD
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Trade (domestic/foreign)
$60,000
Paid to lobbying firm
CitesS. 1919· this member:Cosponsored
Issues related to trade/tariffs in apparel; Issues related to H.R. 7230/S.1919 - Buying American Cotton Act of 2026.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SUPPLY CHAIN FEDERATION · lobbying firm or registrant: WINNING STRATEGIES WASHINGTON
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 20, 2026 · issue area: Transportation
$40,000
Paid to lobbying firm
CitesS. 1404· this member:Cosponsored
Issues around H.R 7758/S.3917 - The Dalilah Law, H.R.2853/S.1404 - Combating Organized Retail Crime Act of 2025, WRDA Reauthorization related to ports, and legislation on Surface Transportation Reauthorization; Issues relati…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ART ASHES · lobbying firm or registrant: ACG ADVOCACY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Arts/Entertainment
$30,000
Paid to lobbying firm
CitesS. 1884· this member:Sponsored
Looted artwork. H.R.4235/S.1884: Holocaust Expropriated Art Recovery (HEAR) Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
STERCUS BIOANALYTICS · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$40,000
Paid to lobbying firm
CitesS. 4784· this member:Recorded vote on 1 roll call
Issues related to wastewater surveillance. FY2027 National Defense Authorization Act (H.R. 8800/S. 4784). Implementation of FY2026 National Defense Authorization Act (P.L. 119-60).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
STERCUS BIOANALYTICS · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$40,000
Paid to lobbying firm
CitesS. 4784· this member:Recorded vote on 1 roll call
Issues related to wastewater surveillance. FY2027 National Defense Authorization Act (H.R. 8800/S. 4784).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
MOTION PICTURE ASSOCIATION · lobbying firm or registrant: CAPITOL TAX PARTNERS, LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Taxation/Internal Revenue Code
$50,000
Paid to lobbying firm
CitesS. 5552· this member:Cosponsored
Tax Issues related to film industry, including H.R.10582 and S.5552 - Motion Picture, Television, and Entertainment Revitalization Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN INVESTMENT COUNCIL · lobbying firm or registrant: RESOLUTION PUBLIC AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Housing
$50,000
Paid to lobbying firm
CitesH.R. 6644· this member:Recorded votes on 9 roll calls
H.R.6644 - 21st Century ROAD to Housing Act, issues impacting investor ownership of homes.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
JP MORGAN CHASE HOLDINGS · lobbying firm or registrant: RESOLUTION PUBLIC AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Banking
$50,000
Paid to lobbying firm
CitesH.R. 3633· this member:Recorded vote on 1 roll call
Issues impacting GSIBs, generally Issues impacting payment systems and credit card interchange, generally HR 3633, Clarity Act Issues related to credit card rate caps
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KOCH GOVERNMENT AFFAIRS, LLC · lobbying firm or registrant: KOCH GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Banking
$6,770,000
Spent on own lobbying
CitesH.R. 6644· this member:Recorded votes on 9 roll calls
Issues related to H.R. 6644 - 21st Century ROAD to Housing Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KOCH GOVERNMENT AFFAIRS, LLC · lobbying firm or registrant: KOCH GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$6,770,000
Spent on own lobbying
CitesH.Con.Res. 14· this member:Recorded votes on 23 roll calls
…nitored implementation of P.L. 117-169; Monitoring the FY2026 and FY2027 budget and appropriations process; FY2026 Financial Services draft; Presidents budget; H. Con. Res. 14 / S. Con. Res. 7, the FY2025 budget resolution, as they relate to taxes; FY2026 Energy and Water draft; Monitored implementation of P.L. 119-75; Consolidated A…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KOCH GOVERNMENT AFFAIRS, LLC · lobbying firm or registrant: KOCH GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$6,770,000
Spent on own lobbying
CitesH.R. 6500· this member:Recorded votes on 4 roll calls
…tation of P.L. 119-74; H.R. 8495, Financial Services and General Government Appropriations Act of 2027; H.R. 9022, Energy and Water Appropriations Act of 2027; H.R. 6500, the Continuing Appropriations and Extensions Act of 2027.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KOCH GOVERNMENT AFFAIRS, LLC · lobbying firm or registrant: KOCH GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$6,770,000
Spent on own lobbying
CitesS.Con.Res. 7· this member:Recorded votes on 27 roll calls
…tion of P.L. 117-169; Monitoring the FY2026 and FY2027 budget and appropriations process; FY2026 Financial Services draft; Presidents budget; H. Con. Res. 14 / S. Con. Res. 7, the FY2025 budget resolution, as they relate to taxes; FY2026 Energy and Water draft; Monitored implementation of P.L. 119-75; Consolidated Appropriations Act…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KOCH GOVERNMENT AFFAIRS, LLC · lobbying firm or registrant: KOCH GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Taxation/Internal Revenue Code
$6,770,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…ional tax / OECD issue; Issues related to the expiration of the 2017 Tax Cut and Jobs Act, particularly corporate and energy taxes; Monitored implementation of H.R. 1, One Big Beautiful Bill Act (P.L. 119-21); Issues related to Treasury reform; H.R. 2918, Family Business Legacy Act; Issues related to tax reform; Employee ben…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing